Epoch Biosciences, Inc.
Epoch Biosciences, Inc. (Epoch Biosciences) is a biotechnology company engaged in the development and sale of products with applications in the genomics and molecular diagnostics fields. The technology of the company is used for the detection of inherited diseases, single nucleotide polymorphisms to identify individuals at risk for disease or adverse drug reactions, and gene expression measurement. The chemical reagents of the company aids to improve the performance of genetic analysis procedures. The products of the company include; MGB Eclipse; Eclipse probe systems; MGB Eclipse by design; MGB Eclipse Analyte-Specific reagents; chemical intermediates; and modified bases, florescent dyes, and quencher. Epoch Biosciences, Inc. is a subsidiary of ELITech SA. The company is headquartered at Bothell, in Washington, the US.
On May 13, 2009, Epoch Biosciences Inc. filed a voluntary petition for reorganization under Chapter 11 in the US Bankruptcy Court for the District of Delaware.